Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Alkermes to Participate in Two Upcoming Investor Conferences


DUBLIN, Nov. 11, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate at two upcoming investor conferences.

Stifel Healthcare Conference
Date/Time: Monday, Nov. 18, 2024 at 8:35 a.m. ET (1:35 p.m. GMT)

Jefferies London Healthcare Conference
Date/Time: Tuesday, Nov. 19, 2024 at 8:00 a.m. ET (1:00 p.m. GMT)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Alkermes plc Logo

Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg


These press releases may also interest you

at 09:05
HubSpot, the leading customer platform for scaling businesses, today announced it has signed an agreement to acquire Frame AI, an AI-powered conversation intelligence platform. Frame AI's technology transforms unstructured data?such as emails, calls,...

at 09:00
This holiday season, SOUL-CIAL, a lifestyle brand renowned for merging high-quality design with purpose, introduces the "Hang a Little Hope on the Tree" Christmas Gift Set. Available from December 1 through December 31, this exclusive offering allows...

at 09:00
VolitionRx Limited ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has entered into definitive agreements for the purchase and sale of (i) 445,648 shares of its common stock to certain directors and...

at 09:00
With the hectic holiday season in full swing, many Ontario residents find it challenging to keep track of their to-do lists and schedules. They want ideas to get into the holiday spirit and find out where and when events are happening. At Upanup our...

at 09:00
Allegion US, a leader in security products and solutions, is the first to support mobile credentials in Google Wallettm on Wear OS smartwatches. Available starting December 9, 2024, for all Schlage® mobile credentials currently offered in Google...

at 09:00
Bybit, the world's second-largest cryptocurrency exchange by trading volume, in partnership with Block Scholes, unveils its November Option Volatility Report, spotlighting Bitcoin(BTC)'s remarkable milestone of surpassing $100K. This detailed...



News published on and distributed by: